Department of Clinical Pharmacology, Hospital and University Centre of Coimbra, Coimbra, Portugal.
Department of Clinical Pharmacology, University of Coimbra Faculty of Medicine, Coimbra, Portugal.
Braz J Cardiovasc Surg. 2021 Jun 1;36(3):323-330. doi: 10.21470/1678-9741-2020-0322.
Our objective was to identify preoperative risk factors and to develop and validate a risk-prediction model for the need for blood (erythrocyte concentrate [EC]) transfusion during extracorporeal circulation (ECC) in patients undergoing coronary artery bypass grafting (CABG).
This is a retrospective observational study including 530 consecutive patients who underwent isolated on-pump CABG at our Centre over a full two-year period. The risk model was developed and validated by logistic regression and bootstrap analysis. Discrimination and calibration were assessed using the area under the receiver operating characteristic curve (AUC) and the Hosmer-Lemeshow (H-L) test, respectively.
EC transfusion during ECC was required in 91 patients (17.2%). Of these, the majority were transfused with one (54.9%) or two (41.8%) EC units. The final model covariates (reported as odds ratios; 95% confidence interval) were age (1.07; 1.02-1.13), glomerular filtration rate (0.98; 0.96-1.00), body surface area (0.95; 0.92-0.98), peripheral vascular disease (3.03; 1.01-9.05), cerebrovascular disease (4.58; 1.29-16.18), and hematocrit (0.55; 0.48-0.63). The risk model developed has an excellent discriminatory power (AUC: 0,963). The results of the H-L test showed that the model predicts accurately both on average and across the ranges of deciles of risk.
A risk-prediction model for EC transfusion during ECC was developed, which performed adequately in terms of discrimination, calibration, and stability over a wide spectrum of risk. It can be used as an instrument to provide accurate information about the need for EC transfusion during ECC, and as a valuable adjunct for local improvement of clinical practice. Key Findings: Risk factors with the greatest prediction for EC transfusion. Take-Home Message: The implementation of this model would be an important step in optimizing and improving the quality of surgery.
我们的目的是确定体外循环(ECC)期间需要输血(红细胞浓缩物[EC])的术前风险因素,并开发和验证一种预测模型。该模型适用于接受冠状动脉旁路移植术(CABG)的患者。
这是一项回顾性观察性研究,包括 530 例在我们中心接受单纯体外循环下冠状动脉旁路移植术的连续患者。使用逻辑回归和引导分析来开发和验证风险模型。使用接收者操作特征曲线(ROC)下的面积(AUC)和 Hosmer-Lemeshow(H-L)检验分别评估区分度和校准。
在 91 例患者(17.2%)的 ECC 期间需要输注 EC。其中,大多数患者输注 1 个(54.9%)或 2 个(41.8%)EC 单位。最终模型协变量(以优势比表示;95%置信区间)为年龄(1.07;1.02-1.13)、肾小球滤过率(0.98;0.96-1.00)、体表面积(0.95;0.92-0.98)、外周血管疾病(3.03;1.01-9.05)、脑血管疾病(4.58;1.29-16.18)和红细胞压积(0.55;0.48-0.63)。开发的风险模型具有出色的区分能力(AUC:0.963)。H-L 检验结果表明,该模型在平均水平和风险十分位数范围内均能准确预测。
建立了一种预测 ECC 期间 EC 输血的风险模型,该模型在区分度、校准度和稳定性方面表现良好,适用于广泛的风险范围。它可以用作提供 ECC 期间 EC 输血需求的准确信息的工具,并且是改进临床实践的有价值的辅助工具。关键发现:对 EC 输血预测最大的风险因素。结论:该模型的实施将是优化和提高手术质量的重要步骤。